DK2200621T3 - Fremgangsmåder, farmaceutiske sammensætninger og fremstillingsartikler til indgivelse af terapeutiske celler til centralnervesystemet hos dyr - Google Patents
Fremgangsmåder, farmaceutiske sammensætninger og fremstillingsartikler til indgivelse af terapeutiske celler til centralnervesystemet hos dyrInfo
- Publication number
- DK2200621T3 DK2200621T3 DK08831016.4T DK08831016T DK2200621T3 DK 2200621 T3 DK2200621 T3 DK 2200621T3 DK 08831016 T DK08831016 T DK 08831016T DK 2200621 T3 DK2200621 T3 DK 2200621T3
- Authority
- DK
- Denmark
- Prior art keywords
- cns
- methods
- preparations
- animals
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Inorganic Chemistry (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97128407P | 2007-09-11 | 2007-09-11 | |
US12/109,066 US8283160B2 (en) | 2007-09-11 | 2008-04-24 | Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system |
PCT/US2008/075223 WO2009035901A1 (en) | 2007-09-11 | 2008-09-04 | Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2200621T3 true DK2200621T3 (da) | 2012-08-06 |
Family
ID=40432083
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK08831016.4T DK2200621T3 (da) | 2007-09-11 | 2008-09-04 | Fremgangsmåder, farmaceutiske sammensætninger og fremstillingsartikler til indgivelse af terapeutiske celler til centralnervesystemet hos dyr |
Country Status (24)
Country | Link |
---|---|
US (3) | US8283160B2 (da) |
EP (1) | EP2200621B1 (da) |
JP (2) | JP5600294B2 (da) |
KR (2) | KR20150039197A (da) |
CN (2) | CN103181932A (da) |
AT (1) | ATE554778T1 (da) |
AU (1) | AU2008299124B2 (da) |
BR (1) | BRPI0816325B8 (da) |
CA (1) | CA2696892C (da) |
CR (1) | CR11304A (da) |
CY (1) | CY1113120T1 (da) |
DK (1) | DK2200621T3 (da) |
ES (1) | ES2388403T3 (da) |
HR (1) | HRP20120560T1 (da) |
IL (1) | IL204371A (da) |
MX (1) | MX2010002738A (da) |
MY (1) | MY154061A (da) |
PL (1) | PL2200621T3 (da) |
PT (1) | PT2200621E (da) |
RU (1) | RU2468818C2 (da) |
SG (1) | SG184724A1 (da) |
SI (1) | SI2200621T1 (da) |
UA (1) | UA98507C2 (da) |
WO (1) | WO2009035901A1 (da) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8518390B2 (en) * | 2003-06-27 | 2013-08-27 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells |
US8283160B2 (en) | 2007-09-11 | 2012-10-09 | Frey Ii William H | Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system |
EP2153844A1 (en) * | 2008-08-14 | 2010-02-17 | HAUBECK, Hans-Dieter | Human hyaluronidases for axonal regrowth |
CN105766891A (zh) | 2008-08-20 | 2016-07-20 | 人类起源公司 | 改进的细胞组合物及制备所述组合物的方法 |
US8609088B2 (en) | 2011-05-10 | 2013-12-17 | Regents Of The University Of Minnesota | Intranasal delivery of therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases |
US8387798B1 (en) | 2012-04-27 | 2013-03-05 | Abdulmohsen E. A. H. Al-Terki | Mutiple oral and nasal surgical procedures method and kit |
US10022083B2 (en) | 2011-06-02 | 2018-07-17 | Abdulmohsen E. A. H. Al-Terki | Multiple oral and nasal surgical procedures method and kit |
US9821149B2 (en) * | 2011-10-14 | 2017-11-21 | Healthpartners Research & Education | Methods for using ultrasound for enhancing efficiency and targeting of intranasal administration of therapeutic compounds to the central nervous system |
EP2794854B1 (en) | 2011-12-23 | 2018-06-20 | DePuy Synthes Products, Inc. | Detection of human umbilical cord tissue-derived cells |
US20130336928A1 (en) * | 2012-06-18 | 2013-12-19 | Healthpartners Research & Education | Methods and pharmaceutical compositions for treatment of central nervous system disorders with therapeutic agent(s) in patients with concurrent non-cns condition(s) or disorders contraindicating systemic administration of the therapeutic agent(s) |
FR3001974B1 (fr) | 2013-02-08 | 2016-02-12 | Olivier Schussler | Procede de purification de cellules |
RU2522816C1 (ru) * | 2013-02-12 | 2014-07-20 | Российская Федерация, от имени которой выступает Министерство промышленности и торговли Российской Федерации (Минпромторг России) | Композиция для клеточно-заместительной терапии дефектов мягких тканей |
US10279012B2 (en) * | 2013-03-11 | 2019-05-07 | Healthpartners Research & Education | Methods of treating and preventing social communication disorder in patients by intranasal administration of insulin |
SG11201509419QA (en) | 2013-05-15 | 2015-12-30 | Univ Minnesota | Adeno-associated virus mediated gene transfer to the central nervous system |
SG10201805670QA (en) | 2014-01-28 | 2018-08-30 | Buck Inst Res Aging | Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders |
WO2015116735A1 (en) | 2014-01-28 | 2015-08-06 | Mayo Foundation For Medical Education And Research | Methods and combinations for killing senescent cells and for treating senescence-associated diseases and disorders |
EP3114135A4 (en) * | 2014-03-06 | 2018-01-24 | Children's National Medical Center | Treatment of neonatal brain injury with hb-egf |
US11413408B2 (en) | 2014-07-29 | 2022-08-16 | Peter Edenhoffer | Positive pressure inspiration device for delivery of medicaments |
JP6640832B2 (ja) * | 2014-07-29 | 2020-02-05 | ピーター・エデンホッファー | 薬剤送達用陽圧吸入装置 |
US10130657B2 (en) | 2015-02-13 | 2018-11-20 | John C. Hughes | Formulation, apparatus, and methods for treatment of brain trauma |
US10335435B2 (en) | 2015-05-22 | 2019-07-02 | Marco Merida | Method for endoscopically delivering stem cells to the brain using an intranasal, injectable approach |
US20160361253A1 (en) * | 2015-06-13 | 2016-12-15 | Noveome Biotherapeutics, Inc. | Novel Methods for Delivering Therapeutic Agents to the Eye via Nasal Passages |
WO2017011326A1 (en) * | 2015-07-10 | 2017-01-19 | Sanjay Gupta | Nasal foam via cribriform plate for medication delivery to the brain and/or body and for nasal moisturization and hygiene |
CA2995457A1 (en) | 2015-08-13 | 2017-02-16 | Dyax Corp. | Evacuated blood collection tubes containing protease inhibitors for the assessment of contact system activation |
IL262211B2 (en) | 2016-04-15 | 2024-01-01 | Univ Pennsylvania | Gene therapy for the treatment of type II mucositis |
CN106924286A (zh) * | 2017-02-16 | 2017-07-07 | 上海安集协康生物技术股份有限公司 | 一种经鼻腔给药用于帕金森病治疗的神经干细胞制剂 |
CN108732355B (zh) * | 2017-04-25 | 2021-06-25 | 首都医科大学附属北京安定医院 | 一种测定bace1酶切nrg1活性的检测方法及其试剂盒 |
US20190060109A1 (en) * | 2017-08-31 | 2019-02-28 | Gregory Todd Johnson | Method of Preventing Traumatic Brain Injury (TBI) |
BR112020005249A2 (pt) | 2017-09-22 | 2020-09-24 | The Trustees Of The University Of Pennsylvania | terapia de gene para tratar mucopolissacaridose tipo ii |
CN108096280A (zh) * | 2017-12-28 | 2018-06-01 | 上海安集协康生物技术股份有限公司 | 一种神经干细胞滴鼻剂 |
KR20220005900A (ko) * | 2020-07-07 | 2022-01-14 | 가톨릭대학교 산학협력단 | 뇌신경계질환 예방 또는 치료용 약학적 조성물 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5624898A (en) * | 1989-12-05 | 1997-04-29 | Ramsey Foundation | Method for administering neurologic agents to the brain |
US20040266715A1 (en) | 1999-03-31 | 2004-12-30 | Wong Liang Fong | Neurite regeneration |
US6667176B1 (en) * | 2000-01-11 | 2003-12-23 | Geron Corporation | cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells |
WO2000033813A1 (en) * | 1998-12-09 | 2000-06-15 | Chiron Corporation | Administration of neurotrophic agents to the central nervous system |
CN100425287C (zh) | 1999-02-09 | 2008-10-15 | 理化学研究所 | 肿瘤疫苗 |
US6749850B1 (en) * | 1999-08-18 | 2004-06-15 | The General Hospital Corporation | Methods, compositions and kits for promoting recovery from damage to the central nervous system |
US20020169102A1 (en) | 2001-04-03 | 2002-11-14 | Frey William H. | Intranasal delivery of agents for regulating development of implanted cells in the CNS |
JP3886346B2 (ja) | 2001-06-22 | 2007-02-28 | サンバイオ,インコーポレイティド | 骨髄間質細胞由来Schwann細胞を含む神経再生用医薬組成物 |
EP1438942A1 (en) | 2003-01-17 | 2004-07-21 | Schering Oy | An otorhinological drug delivery device |
ES2579804T3 (es) | 2003-12-02 | 2016-08-16 | Celavie Biosciences, Llc | Composiciones y métodos para la propagación de células progenitoras neurales |
WO2007002664A2 (en) * | 2005-06-22 | 2007-01-04 | Massachusetts Institute Of Technology | Propagation of undifferentiated embryonic stem cells in hyaluronic acid hydrogel |
US9456979B2 (en) | 2006-04-27 | 2016-10-04 | Sri International | Adminstration of intact mammalian cells to the brain by the intranasal route |
US8168169B2 (en) * | 2006-08-09 | 2012-05-01 | Mclean Hospital Corporation | Methods and compositions for the treatment of medical disorders |
US8283160B2 (en) | 2007-09-11 | 2012-10-09 | Frey Ii William H | Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system |
-
2008
- 2008-04-24 US US12/109,066 patent/US8283160B2/en active Active
- 2008-09-04 AT AT08831016T patent/ATE554778T1/de active
- 2008-09-04 RU RU2010113932/15A patent/RU2468818C2/ru active
- 2008-09-04 UA UAA201002678A patent/UA98507C2/ru unknown
- 2008-09-04 PT PT08831016T patent/PT2200621E/pt unknown
- 2008-09-04 CA CA2696892A patent/CA2696892C/en active Active
- 2008-09-04 DK DK08831016.4T patent/DK2200621T3/da active
- 2008-09-04 SI SI200830702T patent/SI2200621T1/sl unknown
- 2008-09-04 MY MYPI2010001011A patent/MY154061A/en unknown
- 2008-09-04 CN CN2012105792811A patent/CN103181932A/zh active Pending
- 2008-09-04 EP EP08831016A patent/EP2200621B1/en active Active
- 2008-09-04 PL PL08831016T patent/PL2200621T3/pl unknown
- 2008-09-04 BR BRPI0816325A patent/BRPI0816325B8/pt active IP Right Grant
- 2008-09-04 AU AU2008299124A patent/AU2008299124B2/en active Active
- 2008-09-04 WO PCT/US2008/075223 patent/WO2009035901A1/en active Application Filing
- 2008-09-04 CN CN200880107049A patent/CN101801397A/zh active Pending
- 2008-09-04 KR KR1020157002065A patent/KR20150039197A/ko not_active Application Discontinuation
- 2008-09-04 MX MX2010002738A patent/MX2010002738A/es active IP Right Grant
- 2008-09-04 KR KR1020107007866A patent/KR101504110B1/ko active IP Right Grant
- 2008-09-04 ES ES08831016T patent/ES2388403T3/es active Active
- 2008-09-04 JP JP2010524134A patent/JP5600294B2/ja active Active
- 2008-09-04 SG SG2012066049A patent/SG184724A1/en unknown
-
2010
- 2010-03-09 IL IL204371A patent/IL204371A/en active IP Right Grant
- 2010-03-09 CR CR11304A patent/CR11304A/es unknown
-
2012
- 2012-07-06 HR HRP20120560AT patent/HRP20120560T1/hr unknown
- 2012-07-20 CY CY20121100643T patent/CY1113120T1/el unknown
- 2012-10-08 US US13/647,066 patent/US20130028874A1/en not_active Abandoned
-
2014
- 2014-03-03 JP JP2014040359A patent/JP2014098051A/ja not_active Withdrawn
-
2016
- 2016-03-28 US US15/082,210 patent/US9445991B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2200621T3 (da) | Fremgangsmåder, farmaceutiske sammensætninger og fremstillingsartikler til indgivelse af terapeutiske celler til centralnervesystemet hos dyr | |
WO2013142817A3 (en) | Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo | |
BRPI0612125A2 (pt) | compostos da fórmula (i), processo para a fabricação destes, composto da fórmula iiia, composições farmacêuticas, método para o tratamento e/ou profilaxia de doenças associadas à modulação dos receptores cb1 e uso de compostos | |
BR0313041A (pt) | Compostos; composições farmacêuticas; método para o tratamento e/ou profilaxia de doenças que estão associadas à modulação dos receptores de cb1; e uso de compostos | |
MX2016009666A (es) | Suministro topico de composiciones para la piel que tienen ph bajo. | |
BR112012021086A2 (pt) | composições farmacêuticas de composto espiro-oxindole para administração tópica e seu uso como agentes terapêuticos | |
GEP20125624B (en) | Pyridazine derivatives as smo inhibitors | |
NO20081975L (no) | Diarylamin-inneholdende forbindelser og sammensetninger, og deres anvendelse som modulatorer av C-kit-reseptorer | |
BR112015018087A8 (pt) | composto, composição farmacêutica e uso | |
EA201590880A1 (ru) | Композиции и способы лечения протеинопатий | |
PL417066A1 (pl) | Inhibitory arginazy oraz ich zastosowania terapeutyczne | |
UA98839C2 (en) | N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors | |
WO2007016147A3 (en) | Topical skin protectant and anti-pruritic compositions | |
SA520411787B1 (ar) | مشتقات بنزيميدازول واستخداماتها | |
WO2010028173A3 (en) | Method of treating atrial fibrillation | |
WO2012162439A3 (en) | Compositions comprising fusidic acid and packages therefor | |
WO2011005052A3 (en) | Novel arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same | |
WO2008103378A3 (en) | Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist | |
MX2010002559A (es) | Composiciones y metodos para tratar enfermedades y desordenes inmulogicos e inflamatorios. | |
ATE475374T1 (de) | Crimping- und kantenschutzelemente | |
DK1359939T3 (da) | Sammensætning og fremgangsmåde til potensering af lægemidler | |
MA32628B1 (fr) | Agents antifongiques | |
WO2012089797A3 (en) | A composition containing an alkoxysilane and hyaluronic acid | |
EA201100104A1 (ru) | Фармацевтическая композиция, содержащая статин | |
HK1163526A1 (en) | A medicament for treating schizophrenia comprising cilostazol |